With the increasing crowd of companies, the India nebulizers market is witnessing intense competition among players. The top three players, Omron Healthcare, CareFusion, and Philips Healthcare, collectively accounted for a share of just about 52% in 2014 in this highly fragmented market.
Looking forward, market participants will be compelled to invest in research and development activities aggressively to introduce innovative and advanced products in order to strengthen their position.
A study by the World Health Organization (WHO) states that, in India, deaths due to lung disorders are on a rapid rise. Among every 100,000 deaths, nearly 142 are because of one or the other form of lung disorders, making India rank first in deaths by lung diseases across the world.
Read Full Report: http://www.transparencymarketresearch.com/india-nebulizers-market.html
The prevalence of acute respiratory infections that causes asthma, chronic obstructive pulmonary diseases (COPD), and cystic fibrosis, has also been reporting immense growth over the last few years. According to the country’s National Health Profile 2015, approximately 3.5 million cases of acute respiratory infection were reported in 2014, registering a spike of 140,000 cases compared to that of 2013, and an increase of 30% since 2010.
Nebulizers are highly effective in treating these conditions as they convert liquid medication into the aerosol, which can reach easily into the lungs of patients when inhaled using a mouthpiece. Due to their efficacy and the ease of usage they provide, the popularity of these medical instruments is witnessing an exponential rise in this country.
“Recent trends are indicating towards increasing incidence of chronic respiratory diseases in cities such as Delhi, Kolkata, and Vijayawada, aggravated by vehicular pollution, air pollution, increased population, and escalating number of smokers,” says an analyst. Technological advancements aimed at treating severe respiratory disorders will materialize in an extensive rise in demand for these products in India, providing an opportunity-rich market for participants over the next few years.
Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10655
TMR estimates the India nebulizers market to expand at a CAGR of 25.80% during the period from 2015 to 2023, increasing the opportunity it presents from INR 575.6 mn in 2014 to INR 4,703.4 mn by the end of the forecast period.
Presently, the north zone reports the highest consumption of nebulizers in India. The cold climate and the rising level of pollution have skyrocketed the prevalence of COPD and other respiratory disorders in this zone, which does not look like having a stoppage any time soon. Considering the high efficiency of nebulizers in treating these conditions, their demand is expected to climb rapidly in this zone at a CAGR of 27.50% during the forecast period, retaining its dominant status.
Pneumatic nebulizers currently enjoy the highest demand in India on account of the cost efficiency they provide as compared to mesh and ultrasonic nebulizers. However, mesh nebulizers are projected to register the fastest growth rate over the forecast period.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453